Latest news
Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network - simplywall.stsimplywall.st · Sat, 08 Aug 2026 12:48:30 GMTTempus AI Stock Drops As $1.5B Personalis Deal Ups The MRD Stakes - StocksToTradeStocksToTrade · Sat, 08 Aug 2026 12:37:00 GMTTempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - StocktwitsStocktwits · Sat, 08 Aug 2026 09:15:41 GMTWhy Is Tempus AI Stock Surging on Friday? - BenzingaBenzinga · Fri, 07 Aug 2026 18:21:02 GMTCellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 11:00:39 GMTCellCarta Adds Tempus to CDx Commercialization Lab Network - PR NewswirePR Newswire · Thu, 06 Aug 2026 13:15:00 GMTTempus AI, Inc. (TEM.MX) latest press releases and corporate news - Yahoo Finance UKYahoo Finance UK · Wed, 05 Aug 2026 23:33:04 GMTTempus AI (NASDAQ:TEM) Director David Epstein Sells 370 Shares of Stock - MarketBeatMarketBeat · Wed, 05 Aug 2026 21:52:08 GMT